Refractory ascites

Digestive Diseases

Volumn 23, Issue 1, 2005, Pages 30-38

  Cárdenas, Andrés ^a   Arroyo, Vicente ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Ascites; Cirrhosis; Liver transplantation; Paracentesis; Transjugular intrahepatic portosystemic shunt

Indexed keywords

SODIUM;

ASCITES; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE COURSE; EDEMA; ELECTROLYTE BALANCE; ELECTROLYTE DISTURBANCE; FLUID BALANCE; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; MORTALITY; PARACENTESIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT SELECTION; PORTOSYSTEMIC ANASTOMOSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SODIUM ABSORPTION; SODIUM BLOOD LEVEL; SODIUM RESTRICTION; SODIUM RETENTION; SODIUM URINE LEVEL; STATISTICAL SIGNIFICANCE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ASCITES; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER CIRRHOSIS; PARACENTESIS; PROGNOSIS; RECURRENCE;

EID: 20444472333     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084723     Document Type: Review

References (50)

1. Ginès P, Quintero E, Arroyo V, et al: Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987;7:122-128.
2. Ginès P, Fernández-Esparrach G: Prognosis of ascites; in Arroyo V, Ginès P, Rodés J, Schrier RW (eds): Ascites and Renal Dysfunction in Liver Disease. Malden, Blackwell Science, 1999, pp 431-441.
3. Arroyo V, Ginès P, Gerbes A, et al: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-176.
4. Harris NR, Granger DN: Alterations of hepatic and splanchnic microvascular exchange in cirrhosis: Local factors in the formation of ascites; in Arroyo V, Ginès P, Rodés J, Schrier RW (eds): Ascites and Renal Dysfunction in Liver Disease. Malden, Blackwell Science, 1999, pp 351-362.
5. Cárdenas A, Arroyo V: Mechanisms of sodium and water retention in liver cirrhosis. Best Pract Res Clin Endocrinol Metab 2003;17: 607-622.
6. Martin PY, Ginès P, Schrier RW: Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998;339:533-541.
7. Levy M, Allotey JB: Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis. J Lab Clin Med 1978;92:560-569.
8. Rees CJ, Rose JD, Record CO, et al: Transjugular intrahepatic portosystemic shunt: A limited role in refractory ascites. Eur J Gastroenterol Hepatol 1997;9:969-973.
9. Ming Z, Smyth DD, Lautt WW: Decreases in portal flow trigger a hepatorenal reflex to inhibit renal sodium and water excretion in rats: Role of adenosine. Hepatology 2002;35:167-175.
10. Cárdenas A, Bataller R, Arroyo V: Mechanisms of ascites formation. Clin Liver Dis 2000;4:447-465.
11. Moore KP, Wong F, Ginès P, et al: The management of ascites in cirrhosis: Report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258-266.
12. Salerno F, Borroni G, Moser P, et al: Survival and prognostic factors of cirrhotic patients with ascites: A study of 134 outpatients. Am J Gastroenterol 1993;88:514-519.
13. Moreau R, Delegue P, Pessione F, Hillaire S, Durand F, Lebrec D, Valla DC: Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int 2004; 24:457-464.
14. Allard JP, Chau J, Sandokji K, Blendis LM, Wong F: Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol 2001;96:2442-2447.
15. Gines P, Arroyo V, Vargas V, et al: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991;325:829-835.
16. Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jimenez W, et al: Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987;93:234-241.
17. Ruiz-del-Arbol L, Monescillo A, Jiménez W, Garcia-Plaza A, Arroyo V, Rodés J: Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997;113:579-586.
18. Ginès P, Cardenas, A, Arroyo V, Rodés J: Management of cirrhosis and ascites. N Engl J Med 2004;350:1646-1654.
19. Gines A, Fernandez-Esparrach G, Monescillo A, et al: Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996;111:1002-1010.
20. Sola-Vera J, Minana J, Ricart E, et al: Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003;37:1147-1153.
21. Boyer TD, Haskal Z: The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005;41:386-400.
22. Bureau C, Garcia-Pagan JC, Otal P, et al: Improved clinical outcome using polytetrafluoroethylene coated stents for TIPS: Results of a randomized study. Gastroenterology 2004; 126:469-475.
23. Williams DB, Waugh R, Selby W: Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites. Aust New Zealand J Med 1998;28:620-626.
24. Ochs A, Rossle M, Haag K, et al: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-1197.
25. LeMoine O, Nevens F, Deviere J, et al: TIPS for refractory ascites. A Belgian two-center experience (abstract). Hepatology 1996; 24(suppl):445A.
26. Benner KG, Sahagun G, Saxon R, et al: What predicts survival and resolution of refractory ascites after TIPS? (abstract). Hepatology 1996;24(suppl):449A.
27. Hills C, Miller LS, Ter H, et al: Increased colloid pressure correlates with resolution of refractory ascites after transjugular intrahepatic portal-systemic shunt (TIPS) (abstract). Hepatology 1995;22(suppl):165A.
28. Peron JM, Rousseau H, Vinel JP, et al: TIPS in the treatment of refractory ascites: Results in 31 consecutive patients with cirrhosis (abstract). Gastroenterology 1995;108(suppl): 1145A.
29. Sezai S, Kamisaka K, Hirano M: Effectiveness of transjugular intrahepatic shunt (TIPS) for refractory ascites (abstract). Hepatology 1995; 22(suppl):489A.
30. Thuluvath PJ, Mitchell S, Prescott C, Osterman F: TIPSS for refractory ascites and advanced cirrhosis (abstract). Hepatology 1995; 22(suppl):165A.
31. Shrestha R, McKinley C, Showalter R, et al: Transjugular intrahepatic portosystemic shunt (TIPS) for ascites: The prognostic and predictive value of quantitative liver function tests (abstract). Hepatology 1996;24:449A.
32. Wong F, Sniderman K, Liu P, et al: Transjugular intrahepatic portosystemic stent shunt: Effects on hemodynamics and sodium hemostasis in cirrhosis and refractory ascites. Ann Intern Med 1995;122:816-822.
33. Ferral H, Bjarnason H, Wegryn SA, et al: Refractory ascites. Early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993;189:795-801.
34. Nazarian GK, Bjarnason H, Dietz CA Jr, et al: Refractory ascites: Midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997;205:173-180.
35. Forrest EH, Stanley AJ, Redhead DN, et al: Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Ther 1996;10:801-806.
36. Deschenes M, Dufresne MP, Bao B, et al: Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999;94:1361-1365.
37. Trotter JF, Suhocki PV, Rockey DC: Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: Effect of body weight and Child-Pugh score. Am J Gastroenterol 1998;93:1891-1894.
38. Somberg KA, Lake JR, Tomlanovich SJ, et al: Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function. Hepatology 1995;21:709-716.
39. Crenshaw WB, Gordon FD, McEniff NJ, et al: Severe ascites. Efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996;200:185-192.
40. Martinet JP, Fenyves D, Legault L, et al: Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS). Dig Dis Sci 1997;42:161-166.
41. Quiroga J, Sangro B, Nunez M, et al: Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995;21:709-716.
42. Peron JM, Barange K, Otal P: Transjugular intrahepatic portosystemic shunts in the treatment of refractory ascites: Results in 48 consecutive patients. J Vasc Interv Radiol 2000; 11:1211-1216.
43. Lebrec D, Giuily N, Hadengue A, et al: Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial. J Hepatol 1996;25:135-144.
44. Ginès P, Uriz J, Calahorra B, et al: Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-1847.
45. Rossle M, Ochs A, Gulberg V, et al: A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-1707.
46. Sanyal A, Genning C, Reddy RK, et al: The North American Study for Treatment of Refractory Ascites. Gastroenterology 2003;124: 634-641.
47. Salerno F, Merli M, Riggio O: Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004;40:629-635.
48. Gülberg V, Liss I, Bilzer M, Waggershauser T, Reiser M, Gerbes AL: Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts. Digestion 2002;66:127-130.
49. Chalasani N, Clark WS, Martin LG, Kamean J, Khan A, Patel N, Boyer TD: Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000;118:138-144.
50. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.